Wedbush Lowers PT on Emergent BioSolutions to $31

Symbols: EBS
Share

Wedbush Securities has lowered the price target on Emergent BioSolutions (NYSE: EBS) from $37 to $31 and maintains its Outperform rating.


 
 
< Previous
Wedbush Lowers PT on Travelzoo to $52
Next >
Citigroup Upgrades Post Properties to Buy, PT Lowered to $41
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust